SCHEMBL10041238

SCHEMBL10041238

NCC(=O)C(=O)O

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Glycine SCHEMBL30305905 0.93 OR51E2 (0.67)
SCHEMBL6474897 0.79
Glycine SCHEMBL25424845 0.74 OR51E2 (0.71)
Oxaloacetate SCHEMBL4407472 0.74 OR51E2 (0.59)
SCHEMBL31258772 0.72 GLRA1 (0.47)
SCHEMBL1496478 0.72 GLRA1 (0.47)
Oxalic Acid SCHEMBL11370151 0.72 OR51E2 (0.83)
Glycine SCHEMBL3145399 0.72
Glycine SCHEMBL4884592 0.72 CA4 (0.47)
SCHEMBL2049005 0.72

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 48 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2023052526-A1 METHODS FOR PREPARING PYRIDAZINE COMPOUNDS ETH ZURICH (CH) 2023-04-06 WO claimed
EP-4159743-A1 METHODS FOR PREPARING PYRIDAZINE COMPOUNDS ETH Zurich (CH) 2023-04-05 EP claimed
US-20260146268-A1 METHODS FOR IMPROVING YIELDS OF L-GLUFOSINATE BASF SE (DE) 2026-05-28 US disclosed
US-12559777-B2 Methods for improving yields of L-glufosinate BASF SE (DE) 2026-02-24 US disclosed
CN-119630394-A Chelating agents for cancer treatment 普雷高治疗有限公司 2025-03-14 CN disclosed
CN-119384290-A Therapeutic T cell products 提克瓦阿洛塞尔私人有限公司 2025-01-28 CN disclosed
US-20240424127-A1 IL-7 POLYPEPTIDES, IMMUNOCYTOKINES COMPRISING SAME, AND USES THEREOF BRIGHT PEAK THERAPEUTICS AG (CH) 2024-12-26 US disclosed
CN-119120607-A Method for improving yield of L-glufosinate 巴斯夫欧洲公司 2024-12-13 CN disclosed
CN-119031926-A Spray-dried inhalable biotherapeutic agents for the treatment of diseases 艾维尔勒斯生物公司 2024-11-26 CN disclosed
CN-119013010-A Inhalable or ingestible lactic acid composition for the treatment of chronic lung disease 艾维尔勒斯生物公司 2024-11-22 CN disclosed
CN-118973992-A Synthetic method and application of agrimony phenol compound 港大科桥有限公司 2024-11-15 CN disclosed
US-10179785-B2 Imidazotriazinone or imidazopyrazinone derivatives, and use thereof ST PHARM CO., LTD. (KR) 2019-01-15 US disclosed
US-20170166572-A1 NOVEL IMIDAZOTRIAZINONE OR IMIDAZOPYRAZINONE DERIVATIVES, AND USE THEREOF ST PHARM CO., LTD. (KR) 2017-06-15 US disclosed
EP-3166946-A2 NOVEL IMIDAZOTRIAZINONE OR IMIDAZOPYRAZINONE DERIVATIVES, AND USE THEREOF ST Pharm Co. Ltd. (KR) 2017-05-17 EP disclosed
CN-106604928-A Macrocyclic peptidomimetics for alpha-helical mimicry 罗契斯特大学 2017-04-26 CN disclosed
WO-2016006975-A2 NOVEL IMIDAZOTRIAZINONE OR IMIDAZOPYRAZINONE DERIVATIVES, AND USE THEREOF ST PHARM CO., LTD. (KR) 2016-01-14 WO disclosed
US-20120164702-A1 BIOLOGICAL SYNTHESIS OF DIFUNCTIONAL ALKANES FROM CARBOHYDRATE FEEDSTOCKS CELEXION, LLC (US) 2012-06-28 US disclosed
US-20080096799-A1 COMPOUNDS FOR AND METHODS OF TREATING INSULIN RESISTANCE AND INFLAMMATION FORBES MEDI-TECH (RESEARCH), INC. (US) 2008-04-24 US disclosed
WO-2008031032-A2 COMPOUNDS FOR AND METHODS OF TREATING INSULIN RESISTANCE AND INFLAMMATION TRANSITION THERAPEUTICS INC. (CA) 2008-03-13 WO disclosed
US-4394447-A DIAMMONIUM PHOSPHATE THE UNITED STATES OF AMERICA AS REPRESENTED BY THE SECRETARY OF AGRICULTURE (US) 1983-07-19 US disclosed